[1]
Kuo, C.C.; Weaver, V.; Fadrowski, J.J.; Lin, Y.S.; Guallar, E.; Navas-Aciena, A. Arsenic exposure, hyperuricemia, and gout in US adults. Environ. Int., 2015, 76, 32-40.
[2]
Fenech, G.; Rajzbaum, G.; Mazighi, M.; Blacher, J. Serum uric acid and cardiovascular risk: State of the art and perspectives. Joint Bone Spine, 2014, 81, 392-397.
[3]
Lolekha, P.; Wongwan, P.; Kulkantrakorn, K. Association between serum uric acid and motor subtypes of Parkinson’s disease. J. Clin. Neurosci., 2015, 22, 1264-1267.
[4]
Van, M.M.; Houtman, P.M.; Stricker, B.H.; Spoelstra, P. Hepatic injury caused by benzbromarone. J. Hepatol., 1994, 20, 376-379.
[5]
Felser, A.; Lindinger, P.W.; Schnell, D.; Kratschmar, D.V.; Odermatt, A.; Mies, S.; Jenö, P.; Krähenbühl, S. Hepatocellular toxicity of benzbromarone: Effects on mitochondrial function and structure. Toxicology, 2014, 324, 136-146.
[6]
Lin, H.C.; Daimon, M.; Wang, C.H.; Ho, Y.; Uang, Y.S.; Chiang, S.J.; Wang, L.H. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study. Int. J. Cardiol., 2017, 233, 85-90.
[7]
Dalbeth, N.; Stamp, L. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Semin. Dial., 2007, 20, 391-395.
[8]
Yan, H.F.; Dai, X.D.; Fan, K.T.; Wang, Y. Research on medication regularity of traditional chinese medicine based on hyperuricemia patents. Chin. Tradit. Herbal Drugs, 2016, 8, 376-381.
[9]
Editorial Committee of Pharmacopoeia of Ministry of Health PR
China. China Chemical Industry Press, Beijing, 2015.Part1, pp.
435..
[10]
Jia, H.H.; Yuan, J.; Gou, J.; Li, D.Y. The bacteriostatic, anti-inflammatory and immunomodulating effects of Erding granule. West China J. Pharm. Sci, 2006, 21, 453-456.
[11]
Zhang, G.Y. Efficacy observation of Erding granule on treatment of chronic bronchitis. Hebei J. TCM., 2011, 33, 911-912.
[12]
Masoom, R.S.; Zeid, A.A.; Nafisur, R. Analytical techniques in pharmaceutical analysis: a review. Arab. J. Chem., 2017, 10, S1409-S1421.
[13]
Zeid, A.A.; Nafisur, R.; Masoom, R.S. Review on pharmaceutical impurities, stability studies and degradation products. Rev. Adv. Sci. Eng., 2013, 2, 155-166.
[14]
Nafisur, R.; Syed, N.H.A.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[15]
De Villiers, A.; Venter, P.; Pasch, H. Recent advances and trends in the liquid-chromatography-mass spectrometry analysis of flavonoids. J. Chromatogr. A, 2016, 1430, 16-78.
[16]
Zhe, M.; Shi, Z.H.; Su, M.; Sun, H.W. In vitro metabolism analysis of sulfamerazine in mice liver by ultra performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. Curr. Pharm. Anal., 2018, 14, 17-22.
[17]
Yang, M.; Sun, J.; Lu, Z.; Chen, G.; Guan, S.; Liu, X.; Jiang, B.; Ye, M.; Guo, D.A. Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. J. Chromatogr. A, 2009, 1216(11), 2045-2062.
[18]
Song, H.P.; Zhang, H.; Fu, Y.; Mo, H.Y.; Zhang, M.; Chen, J.; Li, P. Screening for selective inhibitors of xanthine oxidase from Flos Chrysanthemum using ultrafiltration LC-MS combined with enzyme channel blocking. J. Chromatogr. B, 2014, 961, 56-61.
[19]
Kong, L.D.; Yang, C.; Ge, F.; Wang, H.D.; Guo, Y.S. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol., 2004, 93, 325-330.
[20]
Chen, L.Y.; Yin, H.F.; Lan, Z.; Ma, S.W.; Zhang, C.F.; Yang, Z.L.; Li, P.; Lin, B.Q. Anti-hyperuricemic and nephroprotective effects of Smilax China L. J. Ethnopharmacol., 2011, 135, 399-405.
[21]
Huang, J.Q.; Wang, J.; Yin, Z.X.; Guo, R.F.; Chen, J.; Liang, H.Y.; Liu, Y. Comparative study of quercetin and allopurinol on serum uric acid levels and function of liver and kidney in hyperuricemic rats. . J. China Pharm. Univ.,, 2015, 46, 458-463.
[22]
Chen, H.L.; Dong, X.P.; Zhang, M.; Pei, J.; Tang, P.R.; Zhang, Y. Chemical constituents from Viola yedoensis. Chin. Tradit. Herbal Drugs, 2010, 41, 874-877.
[23]
Xu, D.; Hou, F.F.; Wu, L.J.; Kang, Y.G. Chemical constituents of Taraxacum ohwanum Kitag. Chin. J. Chin. Mater. Med., 2004, 29, 278-281.
[24]
Shuang, Y.; Tao, S.; Li, J.Z.; Chao, L.; Yao, Z.; Hong, X.L.; Dong, M.R. Chemical constituents of Lobelia chinensis. Fitoterapia, 2014, 93, 168-174.
[25]
Shi, S.Y.; Zhou, C.X.; Xu, Y.; Tao, Q.F.; Bai, H.; Lu, F.S.; Lin, W.Y.; Chen, H.Y.; Zheng, W.; Wang, L.W. Chemical constituents of Taraxacum mongolicum Hand. Mazz. Chin. J. Chin. Mater. Med., 2008, 33, 1147-1157.
[26]
Shi, S.Y.; Zhang, Y.P.; Huang, K.L.; Zhao, Y.; Liu, S.Q. Flavonoids from Taraxacum mongolicum. Biochem. Syst. Ecol., 2008, 36, 437-440.
[27]
Kuo, P.C.; Wang, T.L.; Lin, Y.T.; Kuo, Y.C.; Leu, Y.L. Chemical constituents from Lobelia chinensis and their anti-virus and anti-inflammatory bioactivities. Arch. Pharm. Res., 2011, 34, 715-722.
[28]
Zhang, C.E.; Xiong, Y.; Dong, Q.; Gao, D.; Zhang, L.L.; Ma, L.N.; Peng, C.; Dong, X.P.; Yan, D. Comparison of reversed-phase liquid chromatography and hydrophilic interaction chromatography for the fingerprint analysis of Radix isatidis. J. Sep. Sci., 2014, 37, 1141-1147.
[29]
Xin, M.T.; Fu, X.T.; Chen, Y.G.; Guo, H.Z. Determination of main free amino acids in Banlangen Keli by UPLC. Chin. J. Chin. Mater. Med, 2011, 36, 3306-3309.
[30]
Reng, G.P.; Tian, L.; Li, Z.; Fu, X.D.; Guo, H.Z.; Chen, Y.G. Determination of free amino acids and connected amino acids in Isatidis Radix by HPLC. Chin. New Drug J., 2014, 23, 99-104.
[31]
Pan, Y.L.; Chen, H.; Li, J.; Li, X.; Chen, W.J. Chemical constituents from extract of Isatidis Radix. Chin. Tradit. Pat. Med 36, 2014, 780-785.
[32]
Yang, S.; Shen, T.; Zhao, L.J.; Li, C.; Zhang, Y.; Lou, H.X.; Ren, D.M. Chemical constituents of Lobelia chinensis. Fitoterapia, 2014, 93, 168-174.
[33]
Zhang, M.Z.; Cao, L.W. Chemical constituents of Lobelia hybrid. J. Peking Univ. Acta Sci. Nat., 1991, 27, 205-209.
[34]
Yang, S.; Li, C.; Wang, S.Q.; Zhao, L.J.; Hou, Z.; Lou, H.X.; Ren, D.M. Chiral separation of two diastereomeric pairs of enantiomers of novel alkaloid-lignan hybrids from Lobelia chinensis and determination of the tentative absolute configuration. J. Chromatogr. A, 2013, 1311, 134-139.
[35]
Zuo, L.; Li, J.; Xu, J.; Yang, J.Z.; Zhang, D.M.; Tong, Y. Studies on chemical constituents in root of Isatis indigotica. Chin. J. Chin. Mater. Med., 2007, 32, 688-691.
[36]
Shi, S.Y.; Zhao, Y.; Zhang, Y.P.; Huang, K.L.; Liu, S.Q. Phenylpropanoids from Taraxacum mongolicum. Biochem. Syst. Ecol., 2008, 36, 716-718.
[37]
Leu, Y.L.; Wang, Y.L.; Huang, S.C.; Shi, L.S. Chemical constituents from roots of Taraxacum formosanum. Chem. Pharm. Bull., 2005, 53, 853-855.
[38]
Michalska, K.; Kisiel, W. Sesquiterpenoids from Taraxacum serotinum. Biochem. Syst. Ecol., 2009, 37, 519-521.
[39]
Liu, J.F.; Zhang, N.L.; Liu, M.Q. A new inositol triester from Taraxacum mongolicum. Nat. Prod. Res., 2014, 28, 420-423.
[40]
Michalska, K.; Kisiel, W. Sesquiterpene lactones from Taraxacum obovatum. Planta Med., 2003, 69, 181-183.
[41]
Shi, S.Y.; Zhou, Q.; Peng, H.; Zhou, C.X.; Hu, M.H.; Tao, Q.F.; Hao, X.J.; Stöckigt, J.; Zhao, Y. Four new constituents from Taraxacum mongolicum. Chin. Chem. Lett., 2007, 18, 1367-1370.
[42]
Michalska, K.; Kisiel, W. Sesquiterpene lactones from Taraxacum erythrospermum. Biochem. Syst. Ecol., 2008, 36, 444-446.
[43]
Michalska, K.; Żylewski, M.; Marciniuk, J.; Kisiel, W. Structural analysis of 1l-chiro-inositol diester from Taraxacumudum. Carbohydr. Res., 2010, 345, 172-174.
[44]
Xiao, P.; Chen, J.W.; Li, X.; Chen, Y.Y. Ultrasound-assisted extraction coupled with SPE-HPLC-DAD for the determination of three bioactive phenylpropanoids from Radix Isatidis. Anal. Methods, 2014, 6, 7547-7553.
[45]
Li, B.; Chen, W.S.; Zhang, H.M.; Zhang, W.D.; Yang, G.J.; Qiao, C.Z. A new alkaloids isolated from tetraploidy banlangen. Acta Pharmacol. Sin., 2003, 38, 430-432.
[46]
Michalska, K.; Kisiel, W. Taxonomically significant guaianolides from Taraxacum obovatum. Biochem. Syst. Ecol., 2004, 32, 765-768.
[47]
Chen, D.; Gong, X.G.; Liu, J.; Wang, D.W.; Yi, K.Y.; Wang, S.F.; Bao, Z.Y. Comparative research on samples of Taraxacum mongolicum Hand. Mazz. extracted by supercritical CO2 fluid extraction and petroleum ether. J. Pharm. Anal., 2010, 30, 619-622.
[48]
Zhu, C.S.; Zhang, B.; Lin, Z.J.; Wan, X.J.; Zhou, Y.; Sun, X.X.; Xiao, M.L. Relationship between high-performance liquid chromatography fingerprints and uric acid-lowering activities of Cichorium intybus L. Molecules, 2015, 20, 9455-9467.
[49]
Li, J.M.; Zhang, X.; Wang, X.; Xie, Y.C.; Kong, L.D. Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice. Eur. L. Pharmaco., 2011, 666, 196-204.
[50]
Habu, Y.; Yano, I.; Takeuchi, A.; Saito, H.; Okuda, M.; Fukatsu, A.; Inui, K. Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2. Biochem. Pharmacol., 2003, 66, 1107-1114.
[51]
Habu, Y.; Yano, I.; Okuda, M.; Fukatsu, A.; Inui, K. Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney. Biochem. Pharmacol., 2005, 69, 993-999.
[52]
Hua, J.; Huang, P.; Zhu, C.M.; Yuan, X.; Yu, C.H. Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice. J. Ethnopharmacol., 2012, 142, 248-252.
[53]
Xu, W.A.; Yin, L.; Pan, H.Y.; Shi, L.; Xu, L.; Zhang, X.; Duan, J.A. Study on the correlation between constituents detected in serum from Rhizoma Smilacis Glabrae and the reduction of uric acid levels in hyperuricemia. J. Ethnopharmacol., 2013, 150, 747-754.
[54]
Yang, Y.; Zhang, D.M.; Liu, J.H.; Hu, L.S.; Xue, Q.C.; Ding, X.Q.; Kong, L.D. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. J. Ethnopharmacol., 2015, 169, 49-59.
70
4